$ARDX
ARDELYX, INC.

2017 Q1 Form 10-K Financial Statement

#000119312517047972 Filed on February 17, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q4 2016
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.050M $5.270M $18.73M
YoY Change 41.36% 28.85% 38.43%
% of Gross Profit
Research & Development $22.39M $26.21M $94.16M
YoY Change 16.3% 105.09% 136.08%
% of Gross Profit
Depreciation & Amortization $594.0K $400.0K $1.295M
YoY Change 91.61% 37.93% 56.21%
% of Gross Profit
Operating Expenses $28.43M $31.48M $112.9M
YoY Change 20.85% 86.51% 111.35%
Operating Profit -$28.43M -$112.9M
YoY Change 20.85% 284.14%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $426.0K $200.0K $508.0K
YoY Change 587.1% -266.67% -294.64%
Pretax Income -$28.01M -$31.27M -$112.4M
YoY Change 19.35% 83.94% 279.05%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$28.01M -$31.28M -$112.4M
YoY Change 19.35% 83.98% 279.42%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$591.7K -$660.3K -$2.801M
COMMON SHARES
Basic Shares Outstanding 47.33M shares 47.30M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q4 2016
SHORT-TERM ASSETS
Cash & Short-Term Investments $173.4M $200.8M $200.8M
YoY Change 1.0% 87.69% 87.66%
Cash & Equivalents $71.21M $74.60M $74.60M
Short-Term Investments $102.2M $126.2M $126.2M
Other Short-Term Assets $4.600M $3.200M $3.200M
YoY Change 15.0% -36.0% -36.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $178.0M $204.0M $204.0M
YoY Change 1.32% 82.09% 82.14%
LONG-TERM ASSETS
Property, Plant & Equipment $8.915M $8.991M $9.000M
YoY Change 93.93% 90.85% 91.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $842.0K $148.0K $100.0K
YoY Change 709.62% 42.31% -50.0%
Total Long-Term Assets $9.757M $9.139M $9.100M
YoY Change 103.23% 85.94% 85.71%
TOTAL ASSETS
Total Short-Term Assets $178.0M $204.0M $204.0M
Total Long-Term Assets $9.757M $9.139M $9.100M
Total Assets $187.8M $213.1M $213.1M
YoY Change 4.03% 82.25% 82.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.893M $5.635M $5.600M
YoY Change 20.88% 102.92% 100.0%
Accrued Expenses $12.80M $12.90M $12.90M
YoY Change 212.2% 871.39% 163.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.31M $19.20M $19.20M
YoY Change 55.03% 148.62% 149.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $767.0K $779.0K $800.0K
YoY Change 162.67% 141.93% 166.67%
Total Long-Term Liabilities $767.0K $779.0K $800.0K
YoY Change 162.67% 141.93% 166.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.31M $19.20M $19.20M
Total Long-Term Liabilities $767.0K $779.0K $800.0K
Total Liabilities $20.08M $19.98M $20.00M
YoY Change 57.5% 148.35% 150.0%
SHAREHOLDERS EQUITY
Retained Earnings -$241.9M -$213.9M
YoY Change 93.58% 110.74%
Common Stock $409.6M $407.1M
YoY Change 39.94% 93.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $167.7M $193.2M $193.2M
YoY Change
Total Liabilities & Shareholders Equity $187.8M $213.1M $213.1M
YoY Change 4.03% 82.25% 82.29%

Cashflow Statement

Concept 2017 Q1 2016 Q4 2016
OPERATING ACTIVITIES
Net Income -$28.01M -$31.28M -$112.4M
YoY Change 19.35% 83.98% 279.42%
Depreciation, Depletion And Amortization $594.0K $400.0K $1.295M
YoY Change 91.61% 37.93% 56.21%
Cash From Operating Activities -$26.76M -$26.56M -$92.53M
YoY Change 64.68% 22.96% 28.8%
INVESTING ACTIVITIES
Capital Expenditures $1.118M -$2.760M $4.866M
YoY Change 459.0% 513.33% 40.88%
Acquisitions
YoY Change
Other Investing Activities $24.09M -$56.47M -$126.2M
YoY Change
Cash From Investing Activities $22.97M -$59.23M -$131.1M
YoY Change -11585.0% 13062.22% 3699.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $190.6M
YoY Change 156.41%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 410.0K 20.00K 191.2M
YoY Change -99.49% 100.0% 154.9%
NET CHANGE
Cash From Operating Activities -26.76M -26.56M -92.53M
Cash From Investing Activities 22.97M -59.23M -131.1M
Cash From Financing Activities 410.0K 20.00K 191.2M
Net Change In Cash -3.380M -85.77M -32.41M
YoY Change -105.23% 289.16% 11475.0%
FREE CASH FLOW
Cash From Operating Activities -$26.76M -$26.56M -$92.53M
Capital Expenditures $1.118M -$2.760M $4.866M
Free Cash Flow -$27.88M -$23.80M -$97.40M
YoY Change 69.47% 12.53% 29.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47327610 shares
CY2011Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
574953 shares
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.125
CY2015Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2172899 shares
CY2015Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.70
CY2016Q2 dei Entity Public Float
EntityPublicFloat
197442141
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34435000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-63479000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.03
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1411000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3914 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1162829 shares
CY2013Q4 ardx Convertible Preferred Stock Warrant Liability
ConvertiblePreferredStockWarrantLiability
6500000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107286000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
60682000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.51
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2815000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1265282 shares
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2014Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2800000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1007724 shares
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2366000
CY2015Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
107004000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3808000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1011000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25964886 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25964886 shares
CY2015Q4 us-gaap Assets
Assets
116946000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
571000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
112031000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
33845000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107004000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
210386000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1919000
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
228000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2777000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
228000
CY2015Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2580000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
34073000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30572000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1328000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
380000
CY2015Q4 us-gaap Liabilities
Liabilities
8045000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
116946000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
322000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7723000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
104000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4711000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8519000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
108901000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.78
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3298000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101488000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1644420 shares
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5027000
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2015Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3300000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
100000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1281086 shares
CY2015Q4 ardx Cash And Cash Equivalents Gross Unrealized Gains
CashAndCashEquivalentsGrossUnrealizedGains
0
CY2015Q4 ardx Cash And Cash Equivalents Gross Unrealized Losses
CashAndCashEquivalentsGrossUnrealizedLosses
0
CY2015Q4 ardx Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
311000
CY2015Q4 ardx Accrued Contract Manufacturing Costs
AccruedContractManufacturingCosts
289000
CY2015Q4 ardx Accrued Professional And Consultant Fees Current
AccruedProfessionalAndConsultantFeesCurrent
272000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3161000
CY2016Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
74598000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
78000
CY2016Q4 us-gaap Cash
Cash
24000000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5103000
CY2016Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
200894000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2583000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47309422 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47309422 shares
CY2016Q4 us-gaap Assets
Assets
213131000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1558000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
203992000
CY2016Q4 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
1454549 shares
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
74520000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
407092000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
126296000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2643000
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
903000
CY2016Q4 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
14.20
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74598000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5635000
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
903000
CY2016Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
126225000
CY2016Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2016Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2016Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
10405000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-71000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
126225000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
75423000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
68639000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
8113000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1439000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2026000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1460000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
684000
CY2016Q4 us-gaap Liabilities
Liabilities
19980000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
213131000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
779000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19201000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1686000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
148000
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13750000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1502000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8991000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14094000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.58
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
193151000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.60
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1263430 shares
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3892000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-213875000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2206626 shares
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3169000
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2016Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3900000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
10187000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2712223 shares
CY2016Q4 ardx Cash And Cash Equivalents Gross Unrealized Gains
CashAndCashEquivalentsGrossUnrealizedGains
0
CY2016Q4 ardx Cash Cash Equivalents And Short Term Investments Gross Unrealized Losses
CashCashEquivalentsAndShortTermInvestmentsGrossUnrealizedLosses
78000
CY2016Q4 ardx Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
200823000
CY2016Q4 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestIntrinsicValue
13574000
CY2016Q4 ardx Cash And Cash Equivalents Gross Unrealized Losses
CashAndCashEquivalentsGrossUnrealizedLosses
0
CY2016Q4 ardx Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
6694000
CY2016Q4 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice
10.54
CY2016Q4 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVest
2640905 shares
CY2016Q4 ardx Cash Cash Equivalents And Short Term Investments Gross Unrealized Gains
CashCashEquivalentsAndShortTermInvestmentsGrossUnrealizedGains
7000
CY2016Q4 ardx Accrued Contract Manufacturing Costs
AccruedContractManufacturingCosts
2705000
CY2016Q4 ardx Accrued Professional And Consultant Fees Current
AccruedProfessionalAndConsultantFeesCurrent
322000
CY2014Q2 ardx Increase In Shares Reserved For Issuance Maximum Shares To Be Issued Up On Exercise Of Stock Options
IncreaseInSharesReservedForIssuanceMaximumSharesToBeIssuedUpOnExerciseOfStockOptions
1153279 shares
CY2015Q2 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
13.91
CY2015Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
74300000
CY2015Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7242992 shares
CY2015Q2 ardx Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
77800000
CY2015Q2 ardx Class Of Warrant Or Right Threshold Ownership Percentage
ClassOfWarrantOrRightThresholdOwnershipPercentage
0.0999 pure
CY2015Q2 ardx Warrant Expiration Term
WarrantExpirationTerm
P5Y
CY2015Q3 ardx Payment Received On Termination Of Option And License Agreement
PaymentReceivedOnTerminationOfOptionAndLicenseAgreement
0
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1007724 shares
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.206 pure
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1484000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
72851000
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.046 pure
CY2014 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
56155000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1692000
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.179 pure
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7287000
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
300000
CY2014 us-gaap Depreciation
Depreciation
302000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3214000
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.032 pure
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1593000
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.021 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2014 us-gaap Revenues
Revenues
31623000
CY2014 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
647000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10000
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
122000
CY2014 us-gaap Licenses Revenue
LicensesRevenue
18394000
CY2014 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
71000
CY2014 us-gaap Operating Expenses
OperatingExpenses
33187000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-3214000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3147000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1856000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3852000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
831000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-96000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-1564000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
61310000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6755000
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
721000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
67000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
13397000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1856000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
61241000
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
336398 shares
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
999000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
800000
CY2014 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
208000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
24.41
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
56155000
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.21
CY2014 us-gaap Stock Issued1
StockIssued1
208000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
500000
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.71
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
238000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25900000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.94 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
188888 shares
CY2014 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
4084 shares
CY2014 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.53
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0179 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4084 shares
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1692000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M19D
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10248337 shares
CY2014 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
13229000
CY2014 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
10000 shares
CY2014 ardx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Repurchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsRepurchased
3511 shares
CY2014 ardx Unrecognized Tax Benefits Increase Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions
405000
CY2014 ardx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsExercisedInPeriod
0 shares
CY2014 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Issuance Of Common Stock For Services In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuanceOfCommonStockForServicesInPeriodGross
0 shares
CY2014 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Authorized In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAuthorizedInPeriodGross
0 shares
CY2014 ardx Reclassification Of Warrant Liability To Additional Paid In Capital Upon Completion Of Initial Public Offering
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapitalUponCompletionOfInitialPublicOffering
8049000
CY2014 ardx Reclassification Of Convertible Preferred Warrant Liability To Additional Paid In Capital
ReclassificationOfConvertiblePreferredWarrantLiabilityToAdditionalPaidInCapital
8049000
CY2014 ardx Share Based Compensation Arrangements By Share Based Payment Award Options Issuance Of Common Stock For Services In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuanceOfCommonStockForServicesInPeriodWeightedAverageExercisePrice
0
CY2014 ardx Share Based Compensation Arrangements By Share Based Payment Award Options Repurchased In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsRepurchasedInPeriodWeightedAverageExercisePrice
0.55
CY2014 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Repurchased In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasedInPeriodGross
3511 shares
CY2014 ardx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsAuthorized
1452661 shares
CY2015 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
351000
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1544744 shares
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2634000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-282000
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.29
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.038 pure
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2634000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13530000
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
800000
CY2015 us-gaap Depreciation
Depreciation
829000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29621000
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.017 pure
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001 pure
CY2015 us-gaap Cost Of Services Amortization
CostOfServicesAmortization
107000
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.307 pure
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
718000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-29000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-71840000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3454000
CY2015 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
30000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.91
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0164 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
28563 shares
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
2634000
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2015 us-gaap Revenues
Revenues
24026000
CY2015 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2000000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
900000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-261000
CY2015 us-gaap Licenses Revenue
LicensesRevenue
21611000
CY2015 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
659000
CY2015 us-gaap Operating Expenses
OperatingExpenses
53415000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-29621000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29650000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3454000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2584000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-371000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4083000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-29389000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
75012000
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-65000
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
69000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-47053000
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
9100000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
74323000
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
77784 shares
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.013 pure
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
194000
CY2015 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
19.60
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.41
CY2015 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
30000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2400000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
541000
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.42
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
111000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39885000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.75 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
379709 shares
CY2015 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
28563 shares
CY2015 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
548000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M21D
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22892640 shares
CY2015 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2415000
CY2015 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
13285 shares
CY2015 ardx Unrecognized Tax Benefits Increase Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions
-58000
CY2015 ardx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsExercisedInPeriod
0 shares
CY2015 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Issuance Of Common Stock For Services In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuanceOfCommonStockForServicesInPeriodGross
0 shares
CY2015 ardx Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
0 shares
CY2015 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Authorized In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAuthorizedInPeriodGross
0 shares
CY2015 ardx Share Based Compensation Arrangements By Share Based Payment Award Options Issuance Of Common Stock For Services In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuanceOfCommonStockForServicesInPeriodWeightedAverageExercisePrice
0
CY2015 ardx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsAuthorized
743569 shares
CY2016 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
86000
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
346000
CY2016 dei Entity Registrant Name
EntityRegistrantName
Ardelyx, Inc.
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4730213 shares
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001437402
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5317000
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-32406000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.80
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.003 pure
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5317000
CY2016 us-gaap Cost Of Services Amortization
CostOfServicesAmortization
194000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.362 pure
CY2016 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
730000
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18734000
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Concentration of Credit Risk</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and short-term investments. The Company is exposed to credit risks in the event of default by the issuers to the extent of the amount recorded in its Consolidated Balance Sheets. Cash, cash equivalents and short-term investments are invested through banks and other financial institutions in the United States.</p> </div>
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1300000
CY2016 us-gaap Depreciation
Depreciation
1295000
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-112458000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.006 pure
CY2016 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2016 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
8282000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1300000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
508000
CY2016 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
631000
CY2016 us-gaap Operating Expenses
OperatingExpenses
112895000
CY2016 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
7600000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-112387000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-112387000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-131076000
CY2016 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-71000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2148000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1562000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-112895000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
191204000
CY2016 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
133810000
CY2016 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
40700000
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
795000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-92534000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4866000
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
190573000
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25134 shares
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of consolidated financial statements in conformity with US&#xA0;GAAP requires management to make estimates and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to revenue, clinical trial accruals, contract manufacturing accruals, fair value of assets and liabilities, income taxes, and stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p> </div>
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.003 pure
CY2016 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
187000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
500000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.42
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
16.67
CY2016 us-gaap Stock Issued1
StockIssued1
187000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6400000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
549000
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.19
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
55000
CY2016 dei Trading Symbol
TradingSymbol
ARDX
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
94161000
CY2016 ardx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsExercisedInPeriod
0 shares
CY2016 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Issuance Of Common Stock For Services In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuanceOfCommonStockForServicesInPeriodGross
0 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.77 pure
CY2016 us-gaap Provision For Lease Losses
ProvisionForLeaseLosses
100000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1524014 shares
CY2016 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
67743 shares
CY2016 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
576000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.69
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0162 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
67743 shares
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
5317000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M27D
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40118522 shares
CY2016 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
20118 shares
CY2016 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0
CY2016 ardx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantAdditionalSharesReserved
1000000 shares
CY2016 ardx Class Of Warrant Or Right Expiration Date Description
ClassOfWarrantOrRightExpirationDateDescription
The warrants are exercisable for an exercise price of $13.91 per share at any time prior to the earlier of (i) 5 years from the date of issuance or (ii) certain changes in control of the Company.
CY2016 ardx Unrecognized Tax Benefits Increase Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions
45000
CY2016 ardx Cash And Cash Equivalents Original Maturity Dates
CashAndCashEquivalentsOriginalMaturityDates
90 days or less
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-23467000
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.83
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
28690000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-28613000
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.70
CY2016 ardx Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
0 shares
CY2016 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Authorized In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAuthorizedInPeriodGross
0 shares
CY2016 ardx Short Term Investments Maturity Period Description
ShortTermInvestmentsMaturityPeriodDescription
Short-term investments consist of debt securities classified as available-for-sale and have maturities greater than 90 days, but less than 365 days from the date of acquisition.
CY2016 ardx Share Based Compensation Arrangements By Share Based Payment Award Options Issuance Of Common Stock For Services In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsIssuanceOfCommonStockForServicesInPeriodWeightedAverageExercisePrice
0
CY2016 ardx Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Options Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantOptionsAuthorized
1038595 shares
CY2016 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalSharesReserved
0 shares
CY2016 ardx Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageAdditionalSharesReserved
0
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2015Q1 us-gaap Revenues
Revenues
5883000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
9373000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-3502000
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2015Q2 us-gaap Revenues
Revenues
18143000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
9087000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
9007000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
23529000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-17000000
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
31476000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.70
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
18079000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-18126000
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
29200000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-29031000
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
16876000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-31276000

Files In Submission

Name View Source Status
0001193125-17-047972-index-headers.html Edgar Link pending
0001193125-17-047972-index.html Edgar Link pending
0001193125-17-047972.txt Edgar Link pending
0001193125-17-047972-xbrl.zip Edgar Link pending
ardx-20161231.xml Edgar Link completed
ardx-20161231.xsd Edgar Link pending
ardx-20161231_cal.xml Edgar Link unprocessable
ardx-20161231_def.xml Edgar Link unprocessable
ardx-20161231_lab.xml Edgar Link unprocessable
ardx-20161231_pre.xml Edgar Link unprocessable
d338826d10k.htm Edgar Link pending
d338826dex1029.htm Edgar Link pending
d338826dex1030.htm Edgar Link pending
d338826dex1031.htm Edgar Link pending
d338826dex1032.htm Edgar Link pending
d338826dex1033.htm Edgar Link pending
d338826dex121.htm Edgar Link pending
d338826dex231.htm Edgar Link pending
d338826dex311.htm Edgar Link pending
d338826dex312.htm Edgar Link pending
d338826dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g338826g06k94.jpg Edgar Link pending
g338826g11x25.jpg Edgar Link pending
g338826g67a27.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending